Bio Essence (BIOE) Change in Account Payables (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Change in Account Payables of -$44756.0 in Q1 2026, down 220.08% quarter-over-quarter from $37272.0 in Q4 2025, and down 802.72% on a YoY basis from $6369.0 in Q1 2025.
Bio Essence (BIOE) Change in Account Payables (2020 - 2026) Analysis & Trends
Bio Essence's Change in Account Payables history runs 7 years deep, the most recent figure standing at -$44756.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 802.72% year-over-year to -$44756.0; the TTM figure through Mar 2026 stood at -$20984.0 (down 289.03% YoY), while the FY2025 annual figure was $30141.0, up 470.2% from the prior year.
- Change in Account Payables was -$44756.0 for Q1 2026 at Bio Essence, down from $37272.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $46612.0 in Q2 2024 to a low of -$44756.0 in Q1 2026.
- Historically, Change in Account Payables has averaged -$2031.5 across 5 years, with a median of -$85.0 in 2025.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables jumped 2955.18% in 2022, then slumped 1297.69% in 2024.
- A 5-year view of Change in Account Payables shows it stood at -$25876.0 in 2022, then soared by 88.5% to -$2977.0 in 2023, then plunged by 382.67% to -$14369.0 in 2024, then surged by 359.39% to $37272.0 in 2025, then sank by 220.08% to -$44756.0 in 2026.
- The last three Change in Account Payables figures came in at -$44756.0 (Q1 2026), $37272.0 (Q4 2025), and -$85.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Bio Essence | - | - | 319,353.00 | -44,756.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,756.00 |
| Mar 31, 2026 | -44,756.00 |
| Dec 31, 2025 | 37,272.00 |
| Dec 31, 2025 | 37,272.00 |
| Sep 30, 2025 | -85.00 |
| Sep 30, 2025 | -85.00 |
| Jun 30, 2025 | -13,415.00 |
| Jun 30, 2025 | -13,415.00 |
| Mar 31, 2025 | 6,369.00 |
| Mar 31, 2025 | 6,369.00 |
| Dec 31, 2024 | -14,369.00 |
| Dec 31, 2024 | -14,369.00 |
| Sep 30, 2024 | -27,511.00 |
| Sep 30, 2024 | -27,511.00 |
| Jun 30, 2024 | 46,612.00 |
| Jun 30, 2024 | 46,612.00 |
| Mar 31, 2024 | 554.00 |
| Mar 31, 2024 | 554.00 |
| Dec 31, 2023 | -2,977.00 |
| Dec 31, 2023 | -2,977.00 |